How widespread and convenient <i>H. pylori</i> susceptibility testing will result in pharmacological opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities

Published:2023-01-02 Issue:1 Volume:17 Page:1-7
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Rokkas Theodore¹²^ORCID,Graham David Y.³^ORCID

Affiliation:

1. Gastroenterology Clinic, Henry Dunant Hospital, Athens, Greece

2. Medical School, European University of Cyprus, Nicosia, Cyprus

3. Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA

Funder

Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service grant

funds the Texas Medical Center Digestive Diseases Center

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2023.2162502

Reference28 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Kyoto global consensus report onHelicobacter pylorigastritis

3. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States

4. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus

5. Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review for non-antibiotic treatment of Helicobacter pylori: new insight;Frontiers in Microbiology;2024-05-07

2. H. Pylori Treatment in the COVID-19 Era. What Have We Learned So Far?;Current Gastroenterology Reports;2024-02-02

3. Clinical evaluation of a real-time PCR assay for diagnosis of Helicobacter pylori infection and antibiotic resistance;International Journal of Clinical and Experimental Pathology;2024

4. Advances in the pharmacological and regulatory management of multidrug resistant Helicobacter pylori;Expert Review of Clinical Pharmacology;2023-11-16

5. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention;Nature Reviews Clinical Oncology;2023-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3